Pediatrics - Clinical Physiology and Ethics

Physiological Differences Between Children and Adults Introduction A fundamental principle in pediatric medicine is that children are not simply small adults. Their bodies have distinct physiological characteristics that significantly affect how drugs are absorbed, distributed, metabolized, and eliminated. These differences influence symptom presentation, drug dosing, diagnostic interpretation, and treatment decisions. Understanding these differences is essential for safe and effective pediatric care. Absorption When medications are taken orally, they must be absorbed through the gastrointestinal tract. In children, several factors make this process different from adults. Gastric pH and Drug Degradation Neonates and young infants have higher gastric pH (less acidic) because they produce less gastric acid than adults. This more basic environment affects which drugs can survive in the stomach. Many drugs are designed to be degraded by stomach acid, which normally protects the body from them. However, in infants with higher pH, these acid-sensitive drugs actually survive longer and get absorbed at higher rates. This can lead to unexpectedly high drug levels. Gastric Emptying Infants have slower gastric emptying—the process of food and liquid moving from the stomach into the small intestine. Since absorption primarily occurs in the small intestine, slower emptying means slower drug absorption and delayed peak drug levels. Enzymatic Development The gastrointestinal tract contains enzymes that break down drugs before they're absorbed. These enzyme systems develop gradually with age. Young infants have less enzymatic activity, meaning some drugs pass through the intestinal wall unchanged at higher rates, leading to greater absorption than in older children or adults. Distribution Once a drug is absorbed, it travels through the bloodstream and distributes throughout the body. Children's body composition creates important differences in this process. Total Body Water and Volume of Distribution Children have a much higher proportion of total body water and extracellular fluid compared to adults. This is especially true in infants. For hydrophilic drugs (drugs that dissolve in water, such as beta-lactam antibiotics), this larger fluid compartment means the drug spreads throughout more volume, resulting in a larger volume of distribution. A larger volume of distribution means the drug is more diluted throughout the body, potentially requiring higher doses to achieve therapeutic concentrations. Protein Binding Many drugs bind to plasma proteins (mainly albumin) in the blood. Protein binding affects how much active drug is available to produce effects—only the unbound "free" drug can act on tissues. Infants have fewer plasma proteins than adults. This means highly protein-bound drugs have fewer binding sites available, so more of the drug remains free and active. This increased free concentration can intensify drug effects, which is particularly important when prescribing medications with narrow therapeutic windows. Metabolism Metabolism is how the body chemically transforms drugs into forms that can be eliminated. The liver is the primary organ responsible for drug metabolism, and this process involves two main phases: Phase I Metabolism Phase I includes oxidation, reduction, and hydrolysis reactions—these break down the drug into smaller pieces. These reactions are catalyzed by the cytochrome P450 enzyme system. This system develops gradually throughout childhood. Phase II Metabolism Phase II involves conjugation reactions—attaching water-soluble molecules (like glutathione, sulfate, or glucuronic acid) to the drug to make it easier to excrete. Different conjugation enzymes mature at different rates during development. Variable Maturation Rates The key point is that Phase I and Phase II enzymes develop at different rates. Some are mature by birth; others take weeks or months to develop fully. This creates distinct metabolic patterns: Neonates (first 4 weeks): Have immature Phase I and Phase II metabolism, resulting in slow drug clearance and prolonged half-lives. This is particularly important for drugs that depend on hepatic metabolism. Infants and young children: Gradually develop increased enzyme capacity. Interestingly, once enzymes are mature, some metabolic rates actually exceed those of adults (so-called "hypermetabolism"), requiring relatively higher doses. Older children: Approach adult metabolic patterns as they approach adolescence. The practical consequence is that drug clearance, half-life, and needed dosing intervals all vary dramatically across pediatric age groups. Elimination Drugs and their metabolites must ultimately be eliminated from the body, primarily through the kidneys. Renal elimination differs significantly between children and adults. Renal Clearance in Infants Infants have kidneys that are relatively large compared to their body weight. This anatomical feature means that renal clearance can be quite high in infants—they efficiently filter drugs and metabolites from the blood. However, this statement comes with an important caveat. Preterm Neonates and Immature Kidneys Preterm neonates (those born before 37 weeks gestation) have immature kidney function. Their glomerular filtration rate (the amount filtered per unit time) is lower, and they cannot concentrate urine or reabsorb certain substances as effectively as older infants. Consequently, preterm neonates have reduced drug elimination, and drug accumulation is a significant risk. Disease-Related Considerations Any disease that impairs kidney function—such as acute kidney injury, sepsis, or congenital renal abnormalities—further decreases drug elimination in children. When renal function is compromised, dose adjustments become necessary to prevent toxic drug accumulation. Pediatric Autonomy and Ethical Considerations Legal and Consent Issues: NECESSARYFORREADINGQUESTIONS Children cannot legally make independent medical decisions in most jurisdictions. However, the ethical and legal landscape for pediatric decision-making is nuanced. Guardian Authority and Informed Consent Parents or legal guardians hold decision-making authority for children and must provide informed consent before medical treatment. Informed consent requires that the guardian understands the proposed treatment, alternatives, risks, and benefits. Assent: Beyond Parental Consent Beyond parental consent, there is an important concept called assent—the child's affirmative agreement to participate in treatment, even though they lack legal authority to consent. Assent respects the child as a developing person with emerging autonomy. Best practice recommends obtaining both parental consent and child assent when developmentally appropriate. Adolescent Rights Adolescents may have legal rights to consent to certain healthcare decisions (such as reproductive health or substance abuse treatment) depending on jurisdiction. These rights recognize that older teenagers develop capacities for independent decision-making. Privacy and Confidentiality As children mature, healthcare providers must balance confidentiality with parental information-sharing, creating complex ethical situations about what information to share with parents versus keeping confidential. <extrainfo> Historical Evolution: PROBABLYNOTONEXAM The modern ethical framework for pediatric decision-making emerged from international and professional developments: The United Nations Convention on the Rights of the Child (1989) established the "best-interest standard" as the principle guiding pediatric decision-making. This standard emphasizes that healthcare decisions should prioritize the child's best interests. The American Academy of Pediatrics formally adopted the best-interest standard as an ethical principle in 1995, making it a cornerstone of pediatric ethics in the United States. </extrainfo> Modern Debates: NECESSARYFORREADINGQUESTIONS Pediatric ethics currently grapples with balancing two competing values: Paternalism and Emerging Autonomy Paternalism—acting in a child's best interest without their input—protects children but may limit their developing autonomy. Modern pediatric ethics increasingly recognizes that children develop moral and decision-making capacities gradually. Evidence on Pediatric Understanding Research shows that children can understand moral concepts and feelings from approximately age 12-13. This finding supports the idea that older children should have greater involvement in health-related decisions affecting them. The trend in pediatric ethics is toward shared decision-making that respects the child's emerging autonomy while maintaining appropriate adult oversight. Balancing Act Pediatricians today must navigate this balance: protecting children from harm (paternalism) while gradually transferring decision-making authority as they demonstrate capacity and maturity. This approach recognizes that autonomy develops gradually rather than appearing fully formed at age 18.